JPRN-UMIN000008548已完成未知
Effects of ezetimibe on visceral fat in patients with metabolic syndrome: a randomized controlled study - Fat in METS
Enshu Hospital0 个研究点目标入组 78 人开始时间: 2012年7月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The exclusion criteria were: use of insulin, a history of hypersensitivity to ezetimibe, acute coronary syndrome and brain attacks (infarction or haemorrhage) within 3 months, secondary dyslipidaemia, familiar hypercholesterolaemia, pregnancy and severe hepatic, renal, active inflammatory and malignant diseases.
研究者
相似试验
已完成
2 期
Effect of Ezetimibe on visceral fat suppression in patients with chronic liver disease and hyperlipidemia ; a randomized, double blind, placebo-controlled, clinical trialchronic liver disease with hyperlipidemiaJPRN-UMIN000005540Yokohama City University Medical Center Gastroenterological Center34
尚未招募
不适用
ifestyle and pharmacological regulation of lipoprotein metabolism in the metabolic syndromeType 2 diabetic mellitusDyslipidaemiaDiet and Nutrition - ObesityMetabolic and Endocrine - DiabetesObesityACTRN12606000152527niversity of Western Australia60
已完成
不适用
Effect of ezetimibe on small dense LDL and fatty acids in patients treated with a statin and omega-3 fatty acids supplimentatioDyslipidemiaJPRN-UMIN000012589Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences30
已完成
4 期
Study for the effect of visceral fat reduction by SGLT2 inhibitor Ipragliglozinin patients with type 2 diabetestype 2 diabetes mellitusJPRN-UMIN000014058Hokkaido University Hospital26
已完成
不适用
A study on efficacy of Ezetimibe in patients with Dyslipidemia associated with Digestive disease-Its effect on biliary bigly metabolismhypercholesterolemiaJPRN-UMIN000004183Hiroshima University hospital Department of General Medicine60